Tuesday Oct 27 | Medical News Today
New Study Results Analyzed The Use Of KAPIDEX(TM) (dexlansoprazole)...
New Study Results Analyzed The Use Of KAPIDEX For Nighttime Heartburn In Adults With Non-Erosive GERD Main Category: Acid Reflux / GERD Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 27 Oct 2009 - 1:00 PDT New data being presented at the American College of Gastroenterology 2009 Annual Scientific ...
New combination therapy looks promising against ulcer bacteria
Helicobater pylori , a bacteria implicated in peptic ulcers and gastritis, was eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide and doxycycline compared to eradication in only 80.9 percent of patients on lansoprazole, amoxicillin and clarithromycin for seven days.
Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.
Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.
Metabolic disposition of lansoprazole in relation to the...
NEW Abstract OBJECTIVE: To assess the possible involvement of CYP2C19 in the metabolism of lansoprazole in vivo.
Plavix doesn't mix well with some heartburn meds
For heart disease, stroke patients and people at risk of a stroke, the clot-preventing drug Plavix is a lifesaver.
Lansoprazole 15 mg Once Daily for 14 Days Is Effective for Treatment of Frequent Heartburn
Fast-Track peer review is available for those papers requiring immediate review .
Original Research: Lansoprazole, Ranitidine, and Metoclopramide:...
Nursingcenter.com Exclusively searches the complete text articles from the 50 leading nursing journals available on NursingCenter, including more than 900 continuing education activities, clinical resources and drug updates contained within this website.
Efficacy of a 7-day course of furazolidone, levofloxacin, and...
Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication.
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars .
Novartis Receives FDA Approval to Market Prevacid(R) 24HR as First...
Novartis has announced that Prevacid 24HR has been approved by the FDA as the first OTC Proton Pump Inhibitor for the treatment of frequent heartburn since 2003.
Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.
More Evidence of Problems With PPIs and Plavix
A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.
Takeda to Integrate Its Two Manufacturing Operations in Ireland
Company Limited today announced the integration of its wholly owned subsidiaries Takeda Ireland Limited and Takeda Pharma Ireland Limited into a single operation on July 1, 2009, through a complete transfer of TPI's assets to TIL.
New Studies Show Popular Heartburn Medications Moderate The Effect Of ...
Four of the most commonly prescribed heartburn medications reduce the benefit associated with clopidogrel, a widely used antiplatelet medication also known by its brand name, Plavix.
Common heartburn drugs may reduce anti-clotting medications' benefits
Washington, May 7 : Scientists have found that the medicines used for the treatment of heartburn and ulcers can reduce the anti-clotting action of the medication clopidogrel, thereby resulting in about 50 per cent increase in the combined risk of hospitalisation for heart attack, stroke, and other serious cardiovascular illnesses.
Ulcer drugs offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug.
Plavix increases risk of second heart attack in users of proton-pump inhibitors
PATIENTS WHO are given clopidogrel after a heart attack are at significantly higher risk for another one if they take most proton pump inhibitors to manage their stomach acid, according to a recent study published online by the Canadian Medical Association Journal.
Also on Topix